Brief: Enliven Therapeutics Announces New CEO To Drive Next Phase Of Development
11/12/2025 14:02
Dec 11 (Reuters) - Enliven Therapeutics Inc ELVN.O: ENLIVEN THERAPEUTICS ANNOUNCES NEW CEO TO DRIVE NEXT PHASE OF DEVELOPMENT ENLIVEN THERAPEUTICS INC - RICK FAIR JOINS ENLIVEN AS CEO ENLIVEN THERAPEUTICS INC - RICK FAIR APPOINTED CEO AND BOARD MEMBER EFFECTIVE DEC 11, 2025 Source text: ID:nPn8MKW6Va Further company coverage: ELVN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enliven Therapeutics
See all newsBrief: Enliven Therapeutics Appoints Kristine Ball To Board Of Directors Ahead Of Planned Phase 3 Trial Initiation This Year
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
U.S. RESEARCH ROUNDUP-Caterpillar, Eli Lilly, McKesson
Enliven Therapeutics Q2 net loss widens on higher expenses